Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Leukotriene Modifiers Global Market Report 2025
Request Sample Buy Now
Global Leukotriene Modifiers Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Leukotriene Modifiers Global Market Report 2025

By Drug Type (Montelukast, Zafirlukast, Zileuton ER, Zileuton), By Form (Tablets, Chewable Tablets, Oral Granules), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Leukotriene Modifiers Market Overview

• Leukotriene Modifiers market size has reached to $22.33 billion in 2024

• Expected to grow to $29.25 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%

• Growth Driver: The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leukotriene Modifier Market

• Market Trend: Expansion Of Leukotriene Modifiers Market With Generic And Extended-Release Formulations Boosts Asthma Management

• North America was the largest region in 2024.

What Is Covered Under Leukotriene Modifiers Market?

Leukotriene modifiers refer to a class of medications used to manage and treat allergic rhinitis (hay fever) and asthma. They work by blocking the action or production of leukotrienes, which are chemicals in the body that contribute to inflammation, bronchoconstriction (narrowing of the airways), and mucus production associated with these conditions. By inhibiting leukotrienes, these medications help reduce symptoms such as wheezing, shortness of breath, and nasal congestion.

The main drug types of leukotriene modifiers include montelukast, zafirlukast, zileuton er, and zileuton. Montelukast is a leukotriene receptor antagonist used to prevent and manage asthma and to relieve symptoms of seasonal allergies. The forms are categorized into tablets, chewable tablets, and oral granules distributed through channels such as hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

Leukotriene Modifiers Market Size and growth rate 2025 to 2029: Graph

What Is The Leukotriene Modifiers Market Size 2025 And Growth Rate?

The leukotriene modifiers market size has grown strongly in recent years. It will grow from $22.33 billion in 2024 to $23.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the growing impact of regulatory approvals, rising awareness among healthcare professionals and patients about the benefits of leukotriene modifiers, expiration of patents for certain leukotriene modifier drugs allowed for the entry of generic versions, expansion of indications for leukotriene modifiers, growing collaborations between pharmaceutical companies and healthcare organizations.

What Is The Leukotriene Modifiers Market Growth Forecast?

The leukotriene modifiers market size is expected to see strong growth in the next few years. It will grow to $29.25 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to significant growth opportunities in emerging markets due to increasing healthcare infrastructure and rising disposable incomes shift towards personalized medicine, increasing adoption of telemedicine and remote patient monitoring, ongoing research and development efforts focused on novel drug candidates and formulations, and anticipated changes in regulatory frameworks. Major trends in the forecast period include the integration of digital health technologies such as mobile apps and wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, exploration of novel therapeutic targets, development of patient engagement solutions and tools, and adoption of continuous manufacturing processes for increased efficiency and flexibility in drug production.

The forecast of 5.6% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. allergy and asthma specialists by increasing costs of montelukast and zileuton formulations imported from Spain and Canada, potentially reducing respiratory disease control and raising long-term pharmacotherapy expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Leukotriene Modifiers Market Segmented?

1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton

2) By Form: Tablets, Chewable Tablets, Oral Granules

3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Montelukast: Tablet Formulation, Chewable Tablet Formulation, Oral Granules

2) By Zafirlukast: Tablet Formulation

3) By Zileuton ER: Extended-Release Tablet Formulation

4) By Zileuton: Tablet Formulation, Oral Suspension Formulation

What Is Driving The Leukotriene Modifiers Market? The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leukotriene Modifier Market

The rising incidence of asthma and allergic conditions is expected to propel the growth of the leukotriene modifier market going forward. Asthma and allergic conditions refer to a group of disorders characterized by hypersensitivity reactions of the immune system to various allergens, resulting in inflammation and other symptoms. The increasing incidence of asthma and allergic conditions can be attributed to increased exposure to pollutants, rising temperatures, changing weather patterns, and higher population density. Leukotriene modifiers help manage and alleviate symptoms of asthma and allergic conditions while also improving overall respiratory function, reducing inflammation, and providing a safer and more effective treatment option for patients with chronic respiratory issues. For instance, in May 2024, according to the data published by the National Center for Health Statistics (NCHS), a U.S.-based health statistics agency, the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Additionally, the incidence of asthma episodes in the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, a rising incidence of asthma and allergic conditions is driving the leukotriene modifier industry.

Who Are The Major Players In The Global Leukotriene Modifiers Market?

Major companies operating in the leukotriene modifiers market are Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.

What Are The Key Trends Of The Global Leukotriene Modifiers Market? Expansion Of Leukotriene Modifiers Market With Generic And Extended-Release Formulations Boosts Asthma Management

Major companies operating in the leukotriene modifier market are focusing on developing generic formulations, such as extended-release (ER) tablets, to expand their portfolios and cater to the growing demand for more convenient and effective treatments. Generic extended-release (ER) tablets are pharmaceutical formulations of medications designed to release their active ingredients gradually over an extended period, typically offering convenience and improved dosing schedules compared to immediate-release formulations. For instance, in April 2023, Camber Pharmaceuticals Inc., a US-based pharmaceutical company, added Zileuton ER Tablets to its portfolio. These tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children aged 12 years and older. The tablets are not intended for the reversal of bronchospasm in acute asthma attacks but can be continued during acute exacerbations of asthma. Zileuton ER Tablets are available in 600 mg strength in 120-count bottles.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Leukotriene Modifiers Market? SK Capital Acquires Apotex To Drive Transformation Into Canadian-Based Global Health Company

In April 2023, SK Capital Partners LP., a US-based private investment firm, acquired Apotex Pharmaceutical Holdings Inc. for an undisclosed amount. With this acquisition, SK Capital seeks to leverage the company's iconic brand, broad product portfolio, international presence, and skilled team to drive growth and enhance shareholder value. Apotex Pharmaceutical Holdings Inc. is a Canada-based pharmaceutical company that manufactures leukotriene modifiers such as Montelukast drugs.

What Is The Regional Outlook For The Global Leukotriene Modifiers Market?

North America was the largest region in the leukotriene modifiers market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Leukotriene Modifiers Market?

The leukotriene modifiers market consists of sales of modafinil, armodafinil, amphetamine-based stimulants, fluoxetine, and sertraline. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Leukotriene Modifiers Industry?

The leukotriene modifiers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the leukotriene modifiers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Leukotriene Modifiers Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $23.54 billion
Revenue Forecast In 2034 $29.25 billion
Growth Rate CAGR of 5.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton
2) By Form: Tablets, Chewable Tablets, Oral Granules
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies Subsegments: 1) By Montelukast: Tablet Formulation, Chewable Tablet Formulation, Oral Granules
2) By Zafirlukast: Tablet Formulation
3) By Zileuton ER: Extended-Release Tablet Formulation
4) By Zileuton: Tablet Formulation, Oral Suspension Formulation
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Leukotriene Modifiers Market Characteristics

3. Leukotriene Modifiers Market Trends And Strategies

4. Leukotriene Modifiers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Leukotriene Modifiers Growth Analysis And Strategic Analysis Framework

5.1. Global Leukotriene Modifiers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Leukotriene Modifiers Market Growth Rate Analysis

5.4. Global Leukotriene Modifiers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Leukotriene Modifiers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Leukotriene Modifiers Total Addressable Market (TAM)

6. Leukotriene Modifiers Market Segmentation

6.1. Global Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Montelukast

Zafirlukast

Zileuton ER

Zileuton

6.2. Global Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Chewable Tablets

Oral Granules

6.3. Global Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

6.4. Global Leukotriene Modifiers Market, Sub-Segmentation Of Montelukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablet Formulation

Chewable Tablet Formulation

Oral Granules

6.5. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zafirlukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablet Formulation

6.6. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton ER, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Extended-Release Tablet Formulation

6.7. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablet Formulation

Oral Suspension Formulation

7. Leukotriene Modifiers Market Regional And Country Analysis

7.1. Global Leukotriene Modifiers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Leukotriene Modifiers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukotriene Modifiers Market

8.1. Asia-Pacific Leukotriene Modifiers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukotriene Modifiers Market

9.1. China Leukotriene Modifiers Market Overview

9.2. China Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukotriene Modifiers Market

10.1. India Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukotriene Modifiers Market

11.1. Japan Leukotriene Modifiers Market Overview

11.2. Japan Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukotriene Modifiers Market

12.1. Australia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukotriene Modifiers Market

13.1. Indonesia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukotriene Modifiers Market

14.1. South Korea Leukotriene Modifiers Market Overview

14.2. South Korea Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukotriene Modifiers Market

15.1. Western Europe Leukotriene Modifiers Market Overview

15.2. Western Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukotriene Modifiers Market

16.1. UK Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukotriene Modifiers Market

17.1. Germany Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukotriene Modifiers Market

18.1. France Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukotriene Modifiers Market

19.1. Italy Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukotriene Modifiers Market

20.1. Spain Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukotriene Modifiers Market

21.1. Eastern Europe Leukotriene Modifiers Market Overview

21.2. Eastern Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukotriene Modifiers Market

22.1. Russia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukotriene Modifiers Market

23.1. North America Leukotriene Modifiers Market Overview

23.2. North America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukotriene Modifiers Market

24.1. USA Leukotriene Modifiers Market Overview

24.2. USA Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukotriene Modifiers Market

25.1. Canada Leukotriene Modifiers Market Overview

25.2. Canada Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukotriene Modifiers Market

26.1. South America Leukotriene Modifiers Market Overview

26.2. South America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukotriene Modifiers Market

27.1. Brazil Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukotriene Modifiers Market

28.1. Middle East Leukotriene Modifiers Market Overview

28.2. Middle East Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukotriene Modifiers Market

29.1. Africa Leukotriene Modifiers Market Overview

29.2. Africa Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukotriene Modifiers Market Competitive Landscape And Company Profiles

30.1. Leukotriene Modifiers Market Competitive Landscape

30.2. Leukotriene Modifiers Market Company Profiles

30.2.1. Merck And Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Leukotriene Modifiers Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim International GmbH

31.2. Viatris Inc.

31.3. Teva Pharmaceutical Industries Ltd.

31.4. Hetero Drugs Limited

31.5. Sun Pharmaceutical Industries

31.6. Sumitomo Dainippon Pharma

31.7. Chiesi Farmaceutici S.p.A.

31.8. Cipla Limited

31.9. Aurobindo Pharma Limited

31.10. Dr. Reddy's Laboratories

31.11. Apotex Pharmaceutical Holdings Inc.

31.12. Torrent Pharmaceuticals Ltd.

31.13. DAVA Pharmaceuticals

31.14. Alembic Pharmaceuticals Ltd.

31.15. Starallergens Greer Ltd

32. Global Leukotriene Modifiers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukotriene Modifiers Market

34. Recent Developments In The Leukotriene Modifiers Market

35. Leukotriene Modifiers Market High Potential Countries, Segments and Strategies

35.1 Leukotriene Modifiers Market In 2029 - Countries Offering Most New Opportunities

35.2 Leukotriene Modifiers Market In 2029 - Segments Offering Most New Opportunities

35.3 Leukotriene Modifiers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Leukotriene Modifiers Market, Sub-Segmentation Of Montelukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zafirlukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton ER, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Leukotriene Modifiers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Leukotriene Modifiers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Merck And Co. Financial Performance
  • Table 79: Sanofi SA Financial Performance
  • Table 80: AstraZeneca PLC Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Leukotriene Modifiers Market, Sub-Segmentation Of Montelukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zafirlukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton ER, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Leukotriene Modifiers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Leukotriene Modifiers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Merck And Co. Financial Performance
  • Figure 79: Sanofi SA Financial Performance
  • Figure 80: AstraZeneca PLC Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: GlaxoSmithKline plc Financial Performance

Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Read More About Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

Read More About Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Urology Medical Lasers Market 2022 – By Laser Type (Holmium Laser System, Diode Laser System, Thulium Laser System), By Application (Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (N...

View Report

High Speed Oven Global Market Report 2025 – By Type (Built In, Countertop), By Wattage (1000 - 1250 Watts, 1250 - 1500 Watts, 1500 - 1750 Watts, 1750 - 2000 Watts, 2000 - 2250 Watts, 2250 - 4500 Watts, 4500 - 6000 Watts,...

View Report

Engineered Fluids Global Market Report 2025 – By Type (Heat Transfer Fluids, Lubricants, Solvents, Other Types), By Polymer Type (Polytetrafluoroethylene (PTFE), Polyvinyl Fluoride (PVF), Polyvinylidene Fluoride (PVDF), ...

View Report

Impact Modifiers Global Market Report 2025 – By Type (AIM, ABS, MBS, CPE, EPDM, ASA, Other Types), By Application (PVC, Engineering Plastics, PBT, Nylon, Other Applications), By End-User (Packaging, Construction, Consume...

View Report

Aerospace Tapes Global Market Report 2025 – By Resin Type (Acrylic, Rubber, Silicone, Other Resin Types ), By Backing Material (Paper/Tissue, Film, Foam, Other Backing Material ), By End User (Commercial Aviation, Milita...

View Report

Window Sensors Global Market Report 2025 – By Type (Wired Window Sensors, Wireless Window Sensors), By Distribution Channel (Online, Offline), By Application (Commercial, Household) – Impact of Tariff and Trade War on Ma...

View Report

Frequently Asked Questions

Leukotriene modifiers refer to a class of medications used to manage and treat allergic rhinitis (hay fever) and asthma. They work by blocking the action or production of leukotrienes, which are chemicals in the body that contribute to inflammation, bronchoconstriction (narrowing of the airways), and mucus production associated with these conditions. By inhibiting leukotrienes, these medications help reduce symptoms such as wheezing, shortness of breath, and nasal congestion. For further insights on this market, request a sample here

The market major growth driver - The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leukotriene Modifier Market. For further insights on this market, request a sample here

The leukotriene modifiers market size has grown strongly in recent years. It will grow from $22.33 billion in 2024 to $23.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the growing impact of regulatory approvals, rising awareness among healthcare professionals and patients about the benefits of leukotriene modifiers, expiration of patents for certain leukotriene modifier drugs allowed for the entry of generic versions, expansion of indications for leukotriene modifiers, growing collaborations between pharmaceutical companies and healthcare organizations. The leukotriene modifiers market size is expected to see strong growth in the next few years. It will grow to " $29.25 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to significant growth opportunities in emerging markets due to increasing healthcare infrastructure and rising disposable incomes shift towards personalized medicine, increasing adoption of telemedicine and remote patient monitoring, ongoing research and development efforts focused on novel drug candidates and formulations, and anticipated changes in regulatory frameworks. Major trends in the forecast period include the integration of digital health technologies such as mobile apps and wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, exploration of novel therapeutic targets, development of patient engagement solutions and tools, and adoption of continuous manufacturing processes for increased efficiency and flexibility in drug production. For further insights on this market, request a sample here

The leukotriene modifiers market covered in this report is segmented –
1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton
2) By Form: Tablets, Chewable Tablets, Oral Granules
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies Subsegments:
1) By Montelukast: Tablet Formulation, Chewable Tablet Formulation, Oral Granules
2) By Zafirlukast: Tablet Formulation
3) By Zileuton ER: Extended-Release Tablet Formulation
4) By Zileuton: Tablet Formulation, Oral Suspension Formulation For further insights on this market, request a sample here

North America was the largest region in the leukotriene modifiers market in 2024. The regions covered in the leukotriene modifiers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the leukotriene modifiers market are Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.. For further insights on this market, request a sample here.

Major trends in this market include Expansion Of Leukotriene Modifiers Market With Generic And Extended-Release Formulations Boosts Asthma Management. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Leukotriene Modifiers Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top